Description for experts
The aim of the GMALL registry is to collect data on the diagnosis, treatment and disease progression of ALL in patients 18 years of age with no upper age limit in routine clinical practice, regardless of whether the patient is being treated within a clinical therapy trial or not.
Description for laymen
The aim of the GMALL registry is to collect data on the diagnosis, treatment and disease progression of ALL in patients 18 years of age with no upper age limit in routine clinical practice, regardless of whether the patient is being treated within a clinical therapy trial or not.
JSON Data
{
"short_title": "GMALL-Register",
"data_mode": "900",
"data_mode_number": "000000370",
"official_title": null,
"accrual_state": "running",
"therapeutic_value": "not_applicable",
"therapieansatz_value": "not_applicable",
"therapieintervention_value": "not_applicable",
"therapielinie_value": "first",
"ctgov_number": null,
"eudract_number": null,
"general_contact_email": "sal-aml-register@ukdd.de",
"general_contact_phone": "+49 351-45818380",
"hauptpruefer_dd_name": null,
"description_laie_de": "Das Ziel des GMALL-Registers ist die Erfassung von Daten zur Diagnostik, Behandlung und Krankheitsverlauf der ALL bei Patienten 18 Jahre ohne obere Altersgrenze in der klinischen Routine, unabh\u00e4ngig davon, ob der Patient innerhalb einer klinischen Therapiestudie behandelt wird oder nicht.",
"description_laie_en": "The aim of the GMALL registry is to collect data on the diagnosis, treatment and disease progression of ALL in patients 18 years of age with no upper age limit in routine clinical practice, regardless of whether the patient is being treated within a clinical therapy trial or not.",
"description_expert_de": "Das Ziel des GMALL-Registers ist die Erfassung von Daten zur Diagnostik, Behandlung und Krankheitsverlauf der ALL bei Patienten 18 Jahre ohne obere Altersgrenze in der klinischen Routine, unabh\u00e4ngig davon, ob der Patient innerhalb einer klinischen Therapiestudie behandelt wird oder nicht.",
"description_expert_en": "The aim of the GMALL registry is to collect data on the diagnosis, treatment and disease progression of ALL in patients 18 years of age with no upper age limit in routine clinical practice, regardless of whether the patient is being treated within a clinical therapy trial or not.",
"rechtsgrundlage_value": "BO",
"phase_amg_value": null,
"main_cat_id": 4,
"sub_cat_id": 31
}
